Medical Properties (MPW) Reports Q3 Earnings: What Key Metrics Have to Say

Core Insights - Medical Properties (MPW) reported a revenue of $225.83 million for Q3 2024, marking a year-over-year decline of 26.3% and falling short of the Zacks Consensus Estimate of $241.18 million by 6.37% [1] - The company's EPS for the same quarter was $0.16, down from $0.19 a year ago, and also below the consensus estimate of $0.20, resulting in a surprise of -20.00% [1] Revenue Breakdown - Straight-line rent revenue was reported at $36.60 million, compared to an average estimate of $40.52 million, reflecting a year-over-year increase of 70.2% [3] - Interest and other income was $9.71 million, significantly lower than the average estimate of $19.64 million, representing a year-over-year decline of 67.3% [3] - Rent billed amounted to $169.72 million, slightly above the two-analyst average estimate of $167.14 million, but still a year-over-year decrease of 26% [3] - Income from financing leases was reported at $9.80 million, compared to an average estimate of $18.42 million, indicating a year-over-year decline of 62.4% [3] - The diluted net earnings per share were -$1.34, which was worse than the average estimate of -$0.37 [3] Stock Performance - Over the past month, shares of Medical Properties have returned -11.1%, contrasting with the Zacks S&P 500 composite's increase of +3.2% [4] - The stock currently holds a Zacks Rank 5 (Strong Sell), suggesting potential underperformance relative to the broader market in the near term [4]